PMA device
AccelStim
Orthofix US, LLC · Stimulator, Bone Growth, Non-Invasive (LOF, Class II) · First FDA decision Mar 21, 2025, newest Mar 21, 2025Degenerative disc disease and spinal stenosisFractures and orthopedic trauma
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "AccelStim"
MAUDE reports
0
Brand "AccelStim", since 2015
PubMed studies
0
Mentioning "AccelStim"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AccelStim
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AccelStim", any status and sponsor, newest update first.
- A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal FracturesActive, not recruiting
Orthofix Inc.Public (OFIX)
NCT07286357 · 100 participants (planned) · Start May 30, 2025 · Primary completion Jun 30, 2026
Device: AccelStim (LIPUS) · For: Metatarsal Fracture
Sites: Evanston, Illinois; Mount Prospect, Illinois; Laurel, Maryland
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AccelStim", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOF
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AccelStim"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOF.
- EXOGEN® Ultrasound Bone Healing SystemBioventus, LLC · PMA 2023
- Physio-StimOrthofix, Inc. · PMA 2017
- Cervical-StimOrthofix, Inc. · PMA 2016
- ActaStim-STheragen, Inc. · PMA 2026
- Biomet Ebi Bone Healing SystemAhp Eos Buyer, Inc. · PMA 2013
- OL1000/OL1000 Sc and Spinalogic Bone Growth StimulatorsDjo, LLC · PMA 2012
- ManaFuseEnovis · PMA 2025
- Xstim Spine Fusion StimulatorXstim, Inc. · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.